Abstract
Electroacupuncture (EA) pretreatment can inhibit CRH neurons in the paraventricular nucleus (PVN) of the hypothalamus and improve myocardial ischemia–reperfusion injury (MIRI) by inhibiting sympathetic nerve overactivity. This research offers fresh perspectives on the application of acupuncture in the management of cardiovascular disease.
Introduction
Myocardial ischemia–reperfusion injury (MIRI) is a paradoxical clinical phenomenon where restoring blood flow to the heart after a period of ischemia (such as a heart attack) actually exacerbates tissue damage. While acupuncture has long been suggested as a cardioprotective intervention, the specific neurobiological pathways—the "brain-heart axis"—mediating this effect have remained poorly understood. This study investigates how EA pretreatment at the "Shenmen" (HT7) and "Tongli" (HT5) acupoints modulates specific stress-related neurons in the brain to protect the heart.
The Brain-Heart Circuit: CRH Neurons and Sympathetic Activity
The researchers identified Corticotropin-Releasing Hormone (CRH) neurons in the paraventricular nucleus (PVN) of the hypothalamus as critical mediators. During MIRI, these neurons become hyperactive, triggering a "sympathetic storm" that floods the heart with norepinephrine (NE), leading to increased tissue death.
Using fiber-optic photometry to record real-time calcium signals in living rats, the study demonstrated that EA pretreatment acts as a neural "brake," significantly suppressing the hyperactivity of these PVN-CRH neurons before the injury occurs. This suppression prevents the downstream sympathetic surge, thereby protecting the myocardium from secondary damage.
Experimental Validation via Chemogenetics
To establish causality, the team employed chemogenetics (DREADDs) to selectively manipulate CRH neurons. By using viral vectors to inhibit these neurons, they replicated the cardioprotective effects of EA without the need for acupuncture. Conversely, artificially activating these neurons abolished the benefits of EA, providing definitive evidence that the PVN-CRH-sympathetic axis is the primary pathway for EA-mediated protection.
Key Results in Cardiac Protection
The study's findings show significant improvements across multiple cardiac and autonomic metrics. Rats receiving EA pretreatment exhibited:
- Enhanced Cardiac Function: Significantly higher Left Ventricular Ejection Fraction (LVEF) and Short-axis Shortening (LVFS) compared to the MIRI model group.
- Reduced Electrical Instability: Lower ST-segment deviation on ECGs and improved heart rate variability (LF/HF ratio), indicating a more balanced autonomic nervous system.
- Decreased Tissue Damage: Smaller myocardial infarct areas and lower levels of biochemical markers of heart damage, such as Creatine Kinase-MB.
Conclusion
This research provides a detailed map of the neural circuitry involved in acupuncture-mediated cardioprotection. By identifying the PVN-CRH-sympathetic axis, the study validates EA as a potent "pre-adaptation" strategy that primes the body's internal defenses against ischemic stress. These findings support the clinical application of acupuncture in managing cardiovascular risks and offer a blueprint for future research into brain-heart interactions.
Summary updated